Corcept Therapeutics
CORT
CORT
97 hedge funds and large institutions have $215M invested in Corcept Therapeutics in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 38 increasing their positions, 23 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 98 → 97 (-1)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
97
Holding in Top 10
2
Calls
$675K
Puts
$111K
Top Buyers
| 1 | +$1.69M | |
| 2 | +$765K | |
| 3 | +$757K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$622K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$599K |
Top Sellers
| 1 | -$1.42M | |
| 2 | -$1.03M | |
| 3 | -$737K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$548K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$463K |